Welcome to the Ramakrishnan Lab!
Our laboratory will kick-off July 2021
Postdoctoral positions available!
The research in the lab aims to uncover the cellular and molecular mechanisms behind diabetes and neurodegenerative diseases and engineer therapies that can stop or reverse the disease’s progression. We developed artificial suspended lipid bilayer platforms and single-molecule imaging methods to quantitively dissect the role of exocytosis proteins, SNAREs and their regulators, in type 2 diabetes and Alzheimer’s patients. Understanding the key players of exocytosis can drive therapeutic discovery by clarifying which proteins are critical for each step in the pathway.
We are part of the Department of Pathology and Nanobiology Institute at Yale School of Medicine.